Skip to main content

Table 1 Baseline characteristics and clinical presentation of 201 children for the CHD and non-CHD cohort

From: Effect of congenital heart disease on the recurrence of cough variant asthma in children

Characteristic Non-CHD CHD P value
N = 134 N = 67
N % N %
Clinical presentation
Age (year)      0.99
 1–3 54 40.3 27 40.3  
 4–6 38 28.4 19 28.4  
 7–14 42 31.3 21 31.3  
Sex      0.99
 Male 74 55.2 37 55.2  
 Female 60 44.8 30 44.8  
Family history of allergies 123 91.8 57 85.1 0.150
Family history of eczema 64 47.8 30 44.8 0.689
Family history of asthma 26 19.4 14 20.9 0.803
Laboratory examination      
Elevated eosinophil ratio 44 32.8 18 26.8 0.388
Mycoplasma pneumonia positive 69 51.5 38 56.7 0.484
sIgE sensitization 85 63.4 40 59.7 0.607
Food 70 52.2 32 47.8 0.549
Aeroallergen 84 62.7 37 55.2 0.308
Treatment      0.99
Fluticasone Propionate inhalation aerosol (flixotide) + salbutamol 92 68.7 46 68.7  
Salmeterol xinafoate and fluticasone propionate powder for inhalation (seretide) + salbutamol 42 31.3 21 31.3  
  1. CHD congenital heart disease